Huize Holding Limited — FY2022 Form 20-F
Reporting period: Year ended December 31, 2022; this is an annual report, not a standalone fourth-quarter filing. Financial statements are prepared under U.S. GAAP. Unless otherwise noted, amounts below are in RMB; U.S. dollar equivalents are included where disclosed. The filing provides no clear standalone Q4 results or formal 2023 financial guidance.
Business context
Huize operates an online insurance distribution and services platform in China. It earns primarily commissions from insurer partners and does not underwrite insurance risk. Operations are conducted principally through a PRC variable interest entity (VIE) and subsidiaries controlled through contractual arrangements; investors own shares in the Cayman Islands holding company, not direct equity in the VIE.
Financial and operating performance
| Metric | FY2022 | FY2021 | Change / context |
|---|---|---|---|
| Total operating revenue | RMB1,157.9m (US$167.9m) | RMB2,245.0m | Down 48.4% |
| Brokerage income | RMB1,108.7m | RMB2,232.3m | Down 50.3%; 95.7% of FY2022 revenue |
| Operating loss | RMB43.7m (US$6.3m) | RMB114.4m | Operating margin improved to about -3.8% from -5.1% |
| Net loss | RMB33.7m (US$4.9m) | RMB107.7m | Net margin improved to about -2.9% from -4.8% |
| Operating cash flow | Outflow RMB85.1m (US$12.3m) | Outflow RMB175.9m | Cash burn narrowed |
| Investing cash flow | Outflow RMB56.3m (US$8.2m) | Outflow RMB80.9m | Included RMB26.0m acquisition spending and RMB16.8m purchases of property, equipment and intangibles |
| Financing cash flow | Outflow RMB101.1m (US$14.7m) | Inflow RMB141.9m | Borrowing repayments of RMB367.5m exceeded new borrowings of RMB270.2m |
| Cash and cash equivalents | RMB277.2m (US$40.2m) | RMB381.2m | Restricted cash was RMB98.9m (US$14.3m), versus RMB227.8m |
| Borrowings | RMB150.0m short-term | RMB216.7m short-term plus RMB20.0m long-term | Year-end 2022 bank borrowings were due in 2023 |
Operating costs and expenses fell 49.1% to RMB1,201.6m, broadly in line with the revenue decline. Cost of revenue fell 58.2% to RMB706.0m, mainly due to lower user-traffic channel costs. Selling, general and administrative, and research and development expenses also declined, with staffing reductions and lower marketing activity cited. Other income rose to RMB49.3m from RMB12.8m, principally from technology development and consulting services; it helped reduce, but did not eliminate, the loss.
GWP facilitated was RMB4,907.9m, down 2.2% from RMB5,018.2m. First-year premiums fell 40.9% to RMB1,846.6m, while renewal premiums rose 61.6% to RMB3,061.3m. Cumulative insurance clients increased to 8.4m from 7.5m. Life and health products generated 94.4% of brokerage income; tailor-made products accounted for approximately 64.8% of GWP.
Liquidity, debt and other balance-sheet points
Year-end current assets were RMB750.7m and current liabilities RMB559.1m, approximately 1.34 times current-asset coverage. This measure needs caution: restricted cash includes premiums held for insurers and pledged or guarantee deposits, and cash is concentrated in China and the VIE. Cash plus restricted cash totaled RMB376.1m, down from RMB609.0m. The company reported that available liquidity and expected operating cash flows should cover working capital and capital expenditures for at least 12 months, while warning that future financing may be needed. The 2022 operating cash outflow was affected by working-capital movements, including accounts payable, receivables and insurance premium payables.
Operating lease liabilities were RMB186.1m at year-end; undiscounted lease payments totaled RMB229.5m, including RMB19.1m due within one year. Investment commitments were RMB11.0m. The company reported no dividends paid and no expectation of cash dividends in the foreseeable future.
Changes, outlook, risks and unusual items
- Year-over-year shift: Revenue and first-year premiums contracted sharply after strong 2021 growth. Management attributed the revenue decline mainly to lower first-year premiums; cost-control measures and organizational optimization reduced the loss.
- Management outlook: The filing gives no quantified revenue, earnings or cash-flow guidance. Management expects to continue investing in technology, client services and product offerings, while emphasizing cost control and client acquisition efficiency. It cites COVID-19, economic conditions, insurance demand and evolving regulation as uncertainties.
- Regulatory and operating risks: China’s online insurance, intermediary, data-protection and cybersecurity rules continue to evolve. The filing describes past premium-account misuse and collection of premiums by some unlicensed partners; Huize says it returned misused premiums, ended cooperation with unlicensed entities and is improving controls. The risk of penalties or additional inspections remains.
- Structure and cash mobility: The VIE structure depends on contractual arrangements whose enforceability under PRC law is uncertain. Foreign-exchange controls, statutory reserve requirements and restrictions on transfers from PRC entities may constrain cash movement and dividend payments.
- Financial reporting controls: Management identified a material weakness in internal control over financial reporting due to insufficient personnel with appropriate U.S. GAAP and SEC-reporting expertise. Disclosure controls and internal control over financial reporting were assessed as ineffective at December 31, 2022. Remediation steps include hiring and training; completion is not assured. The auditor gave an unqualified opinion on the financial statements but did not audit internal-control effectiveness.
- Other items: The company recognized RMB7.2m gain from lease terminations and RMB12.8m of government subsidies in 2022. It acquired Shenzhen Detong Insurance Agency; the filing accounts for the transaction as an asset acquisition. No material legal or administrative proceedings were reported as pending. PCAOB inspection access was restored in December 2022, though future access and HFCAA status remain risks.
Important facts for investors to verify
- Reconcile the filing’s year-end Class A share counts: the cover page reports 872,744,986 issued and outstanding, while the audited balance sheet reports 873,068,986 outstanding.
- Review the drivers and durability of lower first-year premiums, higher renewals and the shift in GWP mix; check whether reduced channel spending affected client acquisition or future commissions.
- Assess liquidity quality and access: separate unrestricted cash from premium-related and pledged restricted cash, and confirm repayment or refinancing of the RMB150m borrowing due in 2023.
- Track remediation of the material weakness and whether controls over U.S. GAAP reporting, complex transactions and disclosures become effective.
- Monitor regulatory follow-up on historical premium handling and partner licensing, cybersecurity and data obligations, and any required CSRC filings for future overseas offerings.
- Consider VIE enforceability, cash-transfer restrictions, insurer-partner concentration and the company’s ability to sustain operations without operating cash inflows or external financing.